These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 9750499

  • 21. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for T1c prostate cancer.
    Tanaka N, Fujimoto K, Yoshikawa M, Tanaka M, Hirao Y, Kondo H, Saito I.
    Hinyokika Kiyo; 2007 Jul; 53(7):459-65. PubMed ID: 17702178
    [Abstract] [Full Text] [Related]

  • 22. The significance of prostate-specific antigen alpha-1-antichymotrypsin complex and its indices for the detection of prostate cancer.
    Yamanaka K, Yamada Y, Kobayashi Y, Ueno K, Takechi Y, Hasegawa E, Chikahira Y.
    Hinyokika Kiyo; 2003 Jan; 49(1):5-10. PubMed ID: 12629773
    [Abstract] [Full Text] [Related]

  • 23. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
    Stamey TA, Johnstone IM, McNeal JE, Lu AY, Yemoto CM.
    J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
    [Abstract] [Full Text] [Related]

  • 24. Prostate specific antigen adjusted for transition zone epithelial volume: the powerful predictor for the detection of prostate cancer on repeat biopsy.
    Ohigashi T, Kanao K, Kikuchi E, Nakagawa K, Nakashima J, Marumo K, Murai M.
    J Urol; 2005 May; 173(5):1541-5. PubMed ID: 15821482
    [Abstract] [Full Text] [Related]

  • 25. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
    Iwaki H, Kajita Y, Shimizu Y, Yamauchi T.
    Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
    [Abstract] [Full Text] [Related]

  • 26. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
    Ghafoori M, Varedi P, Hosseini SJ, Asgari M, Shakiba M.
    Urol J; 2009 Mar; 6(3):182-8. PubMed ID: 19711272
    [Abstract] [Full Text] [Related]

  • 27. [Model of screening for prostatic cancer among patients with prostate specific antigen concentration of 4-10 ng/ml in blood].
    Karazanashvili GG, Managadze LG.
    Urologiia; 2000 Mar; (6):37-41. PubMed ID: 11186321
    [Abstract] [Full Text] [Related]

  • 28. Clinical usefulness of serum antip53 antibodies for prostate cancer detection: a comparative study with prostate specific antigen parameters.
    Suzuki H, Akakura K, Igarashi T, Ueda T, Ito H, Watanabe M, Nomura F, Ochiai T, Shimada H.
    J Urol; 2004 Jan; 171(1):182-6. PubMed ID: 14665872
    [Abstract] [Full Text] [Related]

  • 29. Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 ng./ml. combined with free-to-total ratio 20% or less: the Aarau experience.
    Recker F, Kwiatkowski MK, Huber A, Stamm B, Lehmann K, Tscholl R.
    J Urol; 2001 Sep; 166(3):851-5. PubMed ID: 11490232
    [Abstract] [Full Text] [Related]

  • 30. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence.
    Rahardjo D, Kamil ST, Pakasi LS.
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():563-70. PubMed ID: 10895211
    [Abstract] [Full Text] [Related]

  • 31. An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less.
    Zlotta AR, Remzi M, Snow PB, Schulman CC, Marberger M, Djavan B.
    J Urol; 2003 May; 169(5):1724-8. PubMed ID: 12686818
    [Abstract] [Full Text] [Related]

  • 32. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
    Haese A, Dworschack RT, Partin AW.
    J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
    [Abstract] [Full Text] [Related]

  • 33. Proprostate-specific antigen: its usefulness in the era of multiple-core prostate biopsy.
    Miyakubo M, Ito K, Yamamoto T, Takechi H, Ohi M, Suzuki K.
    Int J Urol; 2009 Jun; 16(6):561-5. PubMed ID: 19456991
    [Abstract] [Full Text] [Related]

  • 34. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
    Men S, Cakar B, Conkbayir I, Hekimoglu B.
    J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
    [Abstract] [Full Text] [Related]

  • 35. Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen.
    Uno H, Koide T, Kuriyama M, Ban Y, Deguchi T, Kawada Y.
    Hinyokika Kiyo; 1999 Jul; 45(7):457-61. PubMed ID: 10466060
    [Abstract] [Full Text] [Related]

  • 36. Utility of free prostate specific antigen serum level and its related parameters in the diagnosis of prostate cancer.
    Haroun AA, Hadidy AS, Awwad ZM, Nimri CF, Mahafza WS, Tarawneh ES.
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):291-7. PubMed ID: 21422628
    [Abstract] [Full Text] [Related]

  • 37. Prostate specific antigen adjusted for the transition zone volume as an indicator of prostate cancer.
    Maeda H, Arai Y, Ishitoya S, Okubo K, Aoki Y, Okada T.
    J Urol; 1997 Dec; 158(6):2193-6. PubMed ID: 9366342
    [Abstract] [Full Text] [Related]

  • 38. [PSA density, PSATZ, PSA velocity and PSA doubling time].
    Tochigi T, Kawamura S, Kuwahara M.
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():107-11. PubMed ID: 12599554
    [No Abstract] [Full Text] [Related]

  • 39. [Prostate specific antigen adjusted for the transition zone volume].
    Maeda H, Aoki Y, Arai Y.
    Nihon Rinsho; 2000 Jul; 58 Suppl():108-11. PubMed ID: 11022695
    [No Abstract] [Full Text] [Related]

  • 40. Putting free PSA into play--why and how.
    Check W.
    CAP Today; 2000 Apr; 14(4):1, 14-5, 18-20. PubMed ID: 11066525
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.